Covid-19 vaccine

YSTH NHS FT collaborate in new Covid-19 vaccine trial

York and Scarborough Teaching Hospitals (YSTH) NHS FT are taking part in a study, trailing a new Covid-19 vaccine with the University of York and Tees, Esk and Wear Valleys NHS FT.

Researchers will compare a placebo vaccine with the study vaccine, with participants crossing over during the trial and receiving both. Participants will not know when they are receiving the placebo or the investigational vaccine.

The study will involve a total of 30,000 adult subjects globally, and locally about 150 people, aged between 18 and 40 who have not already had a vaccine for Covid-19.

York is one of nine locations across the UK taking part in the global trial and is a first for the city. The study will also involve Regional Clinical Research Network partners, and is supported by the National Institute for Health Research (NIHR). The trial, based at the University of York, will involve up to ten planned visits to the clinic over a two-year period, but this may be shorter depending upon the on-going results. 

Lydia Harris, Head of Research and Development at York and Scarborough Teaching Hospitals NHS FT, said: “York is rapidly expanding its research capabilities. The quality of our researchers, facilities and patient groups are allowing us to engage effectively in cutting edge research at an international level. We have come a long way in a very short period of time.

“Our staff are doing incredible work to support Covid-19 research studies and we are very proud to have made significant contributions to this global effort.”

Professor Charles Lacey from Hull York Medical School who is the Principal Investigator, leading the local team, said: “Clinical studies are important for medical advances. Current available vaccines are only available because of research study volunteers.

“Although there are several approved Covid-19 vaccines available, research is ongoing to provide more options, since all vaccines may work differently in providing protection against Covid-19. The vaccine we are trialling showed very exciting results in phase 1/2 studies.”  

NHE May/June 22

NHE May/June 22

Developing a high-quality NHS estate

The new edition of NHE’s e-magazine highlights the latest in cyber security, pharmaceuticals, NHS workforce, NHS Estates, driving innovation in procurement and more with articles from the likes of Brendan Griffin-Ryan, Senior Category Manager, Estates & Facilities, NHS SBS (pg79), West London NHS Trust and Health Education England.


View all videos
National Health Executive Presents

National Health Executive Presents

NHE365 Virtual Events

NHE has created a full calendar of events to address the most important issues that influence the delivery of healthcare services. Over 365 days you'll have the opportunity to hear from a range of highly motivating, informative and inspirational speakers. These speakers will equip you with the knowledge and unique insight to enable you to overcome the challenges that you face.

Finger on the Pulse

Ep 14. Health messaging is a science, Professor Craig Jackson

On Episode 14 of NHE's Finger on the Pulse podcast, we're joined by Professor Craig Jackson, Professor of Occupational Health Psychology
Birmingham City University to discuss the coronavirus pandemic, the health messaging around it and how those in power have missed a trick by overlooking the key role of psychology in informing the public of restrictions, measures and the ever-changing situation

More articles...

View all